Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0EN0W
|
|||
| Former ID |
DIB012077
|
|||
| Drug Name |
Teprotumumab
|
|||
| Synonyms |
RV001
Click to Show/Hide
|
|||
| Indication | Graves disease [ICD-11: 5A02.0; ICD-10: E05.0, H06.2] | Approved | [1] | |
| Diabetic macular edema [ICD-11: 9B71.02] | Phase 1 | [2] | ||
| Company |
River vision
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2020 | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.